Short Communication - (2022) Volume 11, Issue 11
Received: 31-Oct-2022, Manuscript No. JTM-22-84379;
Editor assigned: 02-Nov-2022, Pre QC No. P-84379;
Reviewed: 14-Nov-2022, QC No. Q-84379;
Revised: 19-Nov-2022, Manuscript No. R-84379;
Published:
26-Nov-2022
, DOI: 10.37421/2167-1222.2022.11.537
Citation: Khan, Zyan. “Adult Neurogenesis and the Relevance of Function and Brain Repair.” J Trauma Treat 11 (2022): 537.
Copyright: © 2022 Khan Z. This is an open-access article distributed under the terms of the creative commons attribution license which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Adults with acute or chronic brain trauma frequently experience severe neuronal tissue loss and enduring functional impairment. In order to prevent tissue loss or enhance structural and functional regeneration after damage, a number of therapies have been created over the past 20 years to take advantage of the regenerative potential of neural stem cells and the current destiny flexibility of neural cells in the nervous system. We look at existing challenges and restrictions in adult brain stem cell-associated neural repair as well as potential strategies for bringing experimental stem cell therapies closer to the clinic [1].
A common occurrence in many species, including humans, is adult neurogenesis. This type of brain plasticity has therapeutic and functional consequences that are just now starting to be understood. Adult neurogenesis approaches that are compared will provide crucial information regarding brain repair. Here, we contrast the adult neurogenesis of mammals and birds. We discuss recent research on the glial identity of stem cells that produce new neurons, the many migration strategies adopted by the resulting neurons to reach their destinations, and the reactions of these systems to artificially induced cell death. We combine these results to discuss the potential applications of molecular comparative analysis to brain healing.
The brain is always at risk of injury, whether it is acute or chronic. The capacity for regeneration in the adult mammalian brain has long been thought to be severely limited when compared to other tissues such as the skin, liver, or intestines. As a result, the mammalian brain is unable to rebuild structures that have been lost due to harmful events such as ischemic stroke or traumatic brain injury. With acute or chronic injury, however, there is significant functional restoration due to the ability of surviving brain structures to take up at least some of the functions of destroyed tissues. This is seen, for example, in patients who have left-hemispheric strokes and may initially exhibit motor or sensory aphasi [2].
About the neurovascular niche following a cardioembolic stroke, very little is known. Angiogenesis, neurogenesis, and synaptic plasticity are three processes linked to neurorepair that occur naturally in adult brains but can also be induced by endogenous neurorepair phenomena. In order to improve collateral circulation, angiogenesis is stimulated, which results in the formation of new vessels. Intrinsic genetic pathways, growth factors, and environmental factors all have a role in controlling neurogenesis. Blood arteries are tightly linked to the leading process of migrating neural progenitor cells (NPCs), suggesting that this connection gives the NPCs directional guidance. These results imply that blood arteries are crucial as a scaffold for NPC migration to the injured area of the brain.
Following extensive training and rehabilitation, a significant number of patients regain their ability to talk and communicate:
► Similarly, the brain can compensate effectively before the consequences of significant loss of neuronal tissue become apparent.
► Before Parkinson's symptoms appear, more than 80% of dopaminergic neurons in the substantia nigra are thought to be damaged.
► As a result, the adult mammalian brain's ability to repair itself at least functionally is obvious.
► These endogenous repair processes have obvious limitations, leaving a significant percentage of adult brain damage patients with lasting functional abnormalities. As a result, fresh ways for treating degenerative or traumatic brain illnesses must be devised. Exogenous cells have been used in the illness context to either recruit or augment endogenous healing processes or to improve brain function by supplying exogenous cells via transplantation.
► We concentrate solely on existing methodologies and concepts for enhancing brain healing using endogenous Neural Stem Cells (NSCs) or other neural cells. NSCs make new neurons in specific locations of the adult brain, which can be used to target endogenous neurogenesis for brain repair.
Brain repair
One of these is the SVZ, which lines the lateral ventricles and is where NSCs give birth to newborn cells that migrate along the rostral migratory stream into the olfactory bulb (OB), where they differentiate into several types of olfactory neurons. In the rodent brain, SVZ/OB neurogenesis is relatively active, whereas in the human brain, the neurogenic activity of the SVZ appears to be very low or non-existent. In contrast, the hippocampus DG, where NSCs give rise to DG granule cells throughout life, is the second major neurogenic region [3].
Glial repair with neural stem cells
The destiny potential of endogenous NSCs also allows for targeting NSCs to assist glial cell replacement and eventual brain repair, in addition to techniques aimed at enhancing endogenous neurogenesis for neuronal repair in the context of acute or chronic illness. Demyelination in the mouse SVZ, for example, has been shown to result in increased NSC-derived oligodendrocyte production, which may aid in the remyelination of the wounded brain following a lesion. Induced production of oligodendrocytes (which are not produced by DG NSCs under normal conditions) could be used to induce remyelination of the DG circuitry in a variety of demyelinating disorders, including multiple sclerosis and epilepsy.However, possible therapeutic techniques aimed at using endogenous NSCs for glial repair are still being developed, and more research is needed [4,5].
The development of projects by open and private foundations and associations that are responsible for, or focused on, ensuring that their clients' desire for free existences (to the extent that this is feasible) are met is expected to benefit from further logical investigations into the nature (and intervening substrates and instruments) of cooperations between the practical assets of the brain and the biological setting of specific subjects. Professional organisations should take into account that happiness and contentment operate as rewards that encourage additional (sometimes taxing) lifelong learning because they are ultimately powerful drivers of improvement and wellbeing. Increased collaboration between neuroscientists and providers of neurorehabilitative care will help to strengthen the knowledge base and guide decisions regarding the care needed to stay up with and restore age-related declines in mental capacity.
Not applicable.
There is no conflict of interest by the author.
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Journal of Trauma & Treatment received 1048 citations as per Google Scholar report
